Eupraxia Pharmaceuticals Inc. (EPRX)
EPRX trades on Nasdaq in Health Care, Pharmaceuticals and Biotechnology. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$6.68
-8.74% on the day
Market cap
$440.3M
Small cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$38.6M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | EPRX on Nasdaq |
| Sector | Health Care |
| Industry | Pharmaceuticals and Biotechnology |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001581178 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | A1 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$38.6M |
| Operating income | Not in SEC XBRL data |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $80.6M |
| Total assets | $86.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 40-F | 2026-03-13 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-10-09 |
Source: SEC EDGAR submissions feed, 124 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -15.2% |
| 1 month | -18.6% |
| 3 months | +7.1% |
| Year to date | -12.6% |
| 1 year | +9.1% |
| From 52-week high | -27.5% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Pharmaceuticals and Biotechnology
No other listed companies with a market cap share this industry.
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier